Education
About Us
Working with TipRanks
Follow Us
Eiken Chemical Co., Ltd. (JP:4549)
:4549
4549 Stock Chart & Stats
¥2407.00
-¥16.00(-0.73%)
At close: 4:00 PM EST
¥2407.00
-¥16.00(-0.73%)
Day’s Range― - ―
52-Week Range¥1,972.00 - ¥3,345.00
Previous CloseN/A
Volume82.20K
Average Volume (3M)72.32K
Market Cap
¥104.67B
Enterprise Value¥100.27B
Total Cash (Recent Filing)¥4.67B
Total Debt (Recent Filing)¥3.00B
Price to Earnings (P/E)26.7
Beta0.64
Next Earnings
Apr 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.31%
Share Statistics
EPS (TTM)22.51
Shares Outstanding34,541,440
10 Day Avg. Volume81,940
30 Day Avg. Volume72,320
Financial Highlights & Ratios
PEG Ratio-3.65
Price to Book (P/B)1.79
Price to Sales (P/S)1.92
P/FCF Ratio95.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)106.9
Revenue Forecast (FY)¥42.20B
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Equity BaseA very low debt-to-equity ratio and near 70% equity ratio give Eiken durable financial flexibility. This capital structure supports continued R&D, working capital for reagent production, and resilience to demand shocks without needing frequent external financing.
Recurring Consumables RevenueEiken's business hinges on consumable IVD reagents and test kits that require repeat purchases. This built-in pull-through from installed instruments creates predictable, recurring revenue and high customer switching costs, supporting steady cash generation over time.
Strong Operating Cash GenerationOperating cash flow materially exceeds reported net income, indicating high cash conversion from operations. That provides durable internal funding for capex, product support, and working capital, reducing reliance on debt and enabling reinvestment in core diagnostics capabilities.
Bears Say
Declining Net ProfitabilityFalling net margins and lower ROE signal weakening ability to convert revenue into shareholder returns. Over several quarters this compresses internal capital for innovation and dividends, and may indicate cost pressures or pricing limits in core diagnostic product lines.
Weak Free Cash Flow After CapexA sharp decline in free cash flow relative to net income reduces funds available after investments. Persistently weak FCF constrains strategic initiatives, limits buffer for cyclical downturns, and could force trade-offs between R&D, capital spending, and shareholder returns.
Modest Revenue GrowthVery low top-line growth suggests limited market expansion or pricing power in near term. Over a multi-month horizon this restricts operating leverage, making it harder to restore margins and to scale new product launches without gaining share or entering new markets.
Eiken Chemical Co., Ltd. News
4549 FAQ
What was Eiken Chemical Co., Ltd.’s price range in the past 12 months?
Eiken Chemical Co., Ltd. lowest stock price was ¥1972.00 and its highest was ¥3345.00 in the past 12 months.
What is Eiken Chemical Co., Ltd.’s market cap?
Eiken Chemical Co., Ltd.’s market cap is ¥104.67B.
When is Eiken Chemical Co., Ltd.’s upcoming earnings report date?
Eiken Chemical Co., Ltd.’s upcoming earnings report date is Apr 23, 2026 which is in 47 days.
How were Eiken Chemical Co., Ltd.’s earnings last quarter?
Eiken Chemical Co., Ltd. released its earnings results on Jan 30, 2026. The company reported ¥22.51 earnings per share for the quarter, beating the consensus estimate of N/A by ¥22.51.
Is Eiken Chemical Co., Ltd. overvalued?
According to Wall Street analysts Eiken Chemical Co., Ltd.’s price is currently Overvalued.
Does Eiken Chemical Co., Ltd. pay dividends?
Eiken Chemical Co., Ltd. pays a Semiannually dividend of ¥29 which represents an annual dividend yield of 2.31%. See more information on Eiken Chemical Co., Ltd. dividends here
What is Eiken Chemical Co., Ltd.’s EPS estimate?
Eiken Chemical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eiken Chemical Co., Ltd. have?
Eiken Chemical Co., Ltd. has 34,541,440 shares outstanding.
What happened to Eiken Chemical Co., Ltd.’s price movement after its last earnings report?
Eiken Chemical Co., Ltd. reported an EPS of ¥22.51 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.333%.
Which hedge fund is a major shareholder of Eiken Chemical Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4549
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Eiken Chemical Co., Ltd.
Eiken Chemical Co., Ltd. manufactures and sells clinical diagnostics and equipment in Japan. The company is involved in developing clinical diagnostic aids to various aspects of contemporary medicine, including biochemical, immunological, serological, dry chemical diagnosis, and automatic analyzers. It also develops and supplies OC-SENSOR, an automated immunochemical fecal test for detecting gastrointestinal bleeding associated with disorders, such as colorectal cancer, polyps, and diverticulitis. In addition, the company offers real-time turbidi meters, and homeothermal equipment; amplification kits and fluorescence detection reagents for research use; and detection kits. Further, it manufactures a range of products that are used in the field of microbiology; and provides other products comprising immunological and serological reagents. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was founded in 1939 and is headquartered in Tokyo, Japan.
Technical Analysis
PHC Holdings Corp.
―
Techno Medica Co., Ltd.
―
Rion Co., Ltd.
―
Nihon Kohden Corporation
―
Options Prices
Currently, No data available
---